Cite

HARVARD Citation

    Urun, Y. et al. (n.d.). 3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study. European journal of cancer. pp. S686-S687. [Online]. 
  
Back to record